Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Isabelle Ravelingien

Improvements in Productivity and Increased Participation in Daily Activities Over 52 Weeks of Certolizumab Pegol Treatment of Rheumatoid Arthritis: Results of a Belgian Observational Study

Acta Clinica Belgica

Medicine

2018

English

Related publications

Improvements in Productivity at Paid Work and Within the Household, and Increased Participation in Daily Activities After 24 Weeks of Certolizumab Pegol Treatment of Patients With Psoriatic Arthritis: Results of a Phase 3 Double-Blind Randomised Placebo-Controlled Study

Annals of the Rheumatic Diseases

English

Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis in Romania

English

Sustained Improvements in Workplace and Household Productivity and Social Participation With Certolizumab Pegol Over 96 Weeks in Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis

English

Predictors of Sick Leave and Improved Worker Productivity After 52 Weeks of Intensive Treatment in Patients With Early Rheumatoid Arthritis

Scandinavian Journal of Rheumatology

English

Certolizumab Pegol in the Treatment of Axial Spondyloarthritis

Nauchno-Prakticheskaya Revmatologiya

English

Efficacy and Safety of Bimekizumab as Add-On Therapy for Rheumatoid Arthritis in Patients With Inadequate Response to Certolizumab Pegol: A Proof-Of-Concept Study

Annals of the Rheumatic Diseases

English

Pms77 - Decline in Healthcare Resource Consumption for Patients With Rheumatoid Arthritis Starting Certolizumab Pegol Therapy in France (The Eclair Study)

English

Certolizumab Pegol for the Treatment of Crohn’s Disease

Therapeutic Advances in Gastroenterology

Gastroenterology

2011

English

Certolizumab Pegol Is Associated With Long-Term Improvements in Patient-Reported Outcomes in Psoriatic Arthritis: 4-Year Outcomes From the Rapid-Psa Study

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Isabelle Ravelingien

Improvements in Productivity and Increased Participation in Daily Activities Over 52 Weeks of Certolizumab Pegol Treatment of Rheumatoid Arthritis: Results of a Belgian Observational Study

Related publications

Improvements in Productivity at Paid Work and Within the Household, and Increased Participation in Daily Activities After 24 Weeks of Certolizumab Pegol Treatment of Patients With Psoriatic Arthritis: Results of a Phase 3 Double-Blind Randomised Placebo-Controlled Study

Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis in Romania

Sustained Improvements in Workplace and Household Productivity and Social Participation With Certolizumab Pegol Over 96 Weeks in Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis

Predictors of Sick Leave and Improved Worker Productivity After 52 Weeks of Intensive Treatment in Patients With Early Rheumatoid Arthritis

Certolizumab Pegol in the Treatment of Axial Spondyloarthritis

Efficacy and Safety of Bimekizumab as Add-On Therapy for Rheumatoid Arthritis in Patients With Inadequate Response to Certolizumab Pegol: A Proof-Of-Concept Study

Pms77 - Decline in Healthcare Resource Consumption for Patients With Rheumatoid Arthritis Starting Certolizumab Pegol Therapy in France (The Eclair Study)

Certolizumab Pegol for the Treatment of Crohn’s Disease

Certolizumab Pegol Is Associated With Long-Term Improvements in Patient-Reported Outcomes in Psoriatic Arthritis: 4-Year Outcomes From the Rapid-Psa Study